Trial Profile
Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals: a Mono-center, Randomized, Placebo Controlled, Double-blind Study (Phase I)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs PF 6412562 (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 03 Nov 2020 Status changed from recruiting to completed.
- 14 Jun 2017 New trial record